Archives for November 10, 2006

← 2006

Pharma selects CROs on cost and quality criteria

By  Staff Reporter

According to a new report, CRO's are primarily selected on their scientific expertise and the cost/value ratio as pharmaceutical and biotech companies look to speed up the research and development process whilst adhering to stricter guidelines.

NIH employees express dissatisfaction with new rules

By  Staff Reporter

A survey conducted by the National Institute of Health (NIH) has revealed a low level of job satisfaction amongst scientists conducting research at the organisation, exacerbated by the introduction of ethical guidelines.

Wyeth enters into Nanobodies agreement with Ablynx

By  Staff Reporter

Wyeth Pharmaceuticals has announced they have entered into collaboration with Ablynx in a deal, which aims to commercialise a class of antibody-derived therapeutic proteins targeting diseases that include oncology and Alzheimer's disease.

Asterand make available cell ranges for disease research

By  Staff Reporter

Asterand is to make available novel research materials to be used in the investigation of rheumatoid arthritis, osteoarthritis, cancer and other diseases making available a range of cell material that is currently difficult to obtain.